ArticleBlood cancer journal2023

Correction: Combined inhibition of BCL-2 and MCL-1 overcomes BAX deficiency-mediated resistance of TP53-mutant acute myeloid leukemia to individual BH3 mimetics.

Bing Z Carter et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.